Decrease in Growth Hormone and Insulin-like Growth Factor (IGF) - 1 Release and Amelioration of Acromegaly Features after Rosiglitazone Treatment of Type 2 Diabetes Mellitus in a Patient with Acromegaly

Gradi�er, Marina; Matovinovic, Martina; Vrkljan, Milan
February 2007
Croatian Medical Journal;2007, Vol. 48 Issue 1, p87
Academic Journal
No abstract available.


Related Articles

  • Acromegaly presenting with low insulin-like growth factor-1 levels and diabetes: a case report. Wijayaratne, Dilushi Rowena; Arambewela, M. H.; Dalugama, Chamara; Wijesundera, Dishni; Somasundaram, Noel; Katulanda, Prasad // Journal of Medical Case Reports;10/30/2015, Vol. 9, p1 

    Introduction: Acromegaly is an endocrine disorder arising from excessive serum growth hormone levels in adulthood and is characterized by progressive somatic enlargement. Biochemical confirmation is achieved by demonstration of elevated baseline serum growth hormone levels which are...

  • Rheumatoid arthritis masquerading as acromegaly recurrence: report of two cases. Aydın, Yusuf; Coşkun, Hülya; Kır, Seher; Yazici, Selma; Kudaş, Özlem; Güngör, Adem // Rheumatology International;Sep2012, Vol. 32 Issue 9, p2913 

    Acromegaly is a chronic endocrinopathy characterized by hypersecretion of growth hormone (GH) and consequently of insulin-like growth factor-1 (IGF-1). The arthropathy in acromegaly is the most frequent and important cause of morbidity and functional disability in acromegaly. Rheumatoid...

  • FELINE ACROMEGALY: The keys to diagnosis. Wakayama, Justin; Bruyette, David S. // Veterinary Medicine;Oct2013, Vol. 108 Issue 10, p467 

    The article presents information on various methods for the diagnosis of feline acromegaly in cats. Feline acromegaly is a disease involving excessive secretion of growth hormone, resulting in diabetes mellitus, increased body weight, protrusion of the mandible, hypertension, and congestive...

  • Pegvisomant tedavisi sonuçlarımiz ve literatürün gözden geçirilmesi. KILIÇ KAN, Elif; CENGÍ ECEMÎŞ, Gülçin; TURA BAHADIR, Çiğdem; ATMACA, Ayşegül; ATMACA, Hulusi; ÇOLAK, Ramis // Marmara Medical Journal;2013, Vol. 26 Issue 2, p53 

    Acromegaly is a chronic disease characterized by the elevated growth hormone (GH) and insulin-like growth factor-1 (IGF-1) levels. Treatment options for acromegaly are surgery, radiotherapy and medical treatments. Somatostatin analogues, dopamine agonists and pegvisomant are the options for...

  • Osteoarticular Changes in Acromegaly. Killinger, Zdenko; Kužma, Martin; Sterančáková, Lenka; Payer, Juraj // International Journal of Endocrinology;2012, p1 

    Acromegaly is caused by hypersecretion of growth hormone (GH) and consequently of insulin-like growth factor-I (IGF-1) due to pituitary tumor. Other causes, such as increased growth-hormone releasing hormone (GHRH) production, ectopic GHRH production, and ectopic GH secretion, are rare. Growth...

  • Somatostatin analogues important in managing acromegaly.  // Drugs & Therapy Perspectives;Apr2010, Vol. 26 Issue 4, p9 

    The article discusses the use of somatostatin analogues for the treatment of patients with acromegaly. Acromegaly is often caused by a benign pituitary adenoma which results in the excessive production of growth hormone (GH) and insulin-like growth-factor (IGF)-I. Because acromegaly is a...

  • Rosiglitazone as an option for patients with acromegaly: a case series.  // Journal of Medical Case Reports;2011, Vol. 5 Issue 1, p1 

    The article presents four case studies regarding the clinical responses to six months of treatment with rosiglitazone for patients with acromegaly. Despite previous surgical treatment and other conventional therapy, the patients had persistent growth hormone overproduction in all four cases....

  • Acromegaly with Normal Insulin-Like Growth Factor-1 Levels and Congestive Heart Failure as the First Clinical Manifestation. Hyae Min Lee; Sun Hee Lee; In-Ho Yang; In Kyoung Hwang; You Cheol Hwang; Kyu Jeung Ahn; Ho Yeon Chung; Hui-Jeong Hwang; In-Kyung Jeong // Endocrinology & Metabolism;Sep2015, Vol. 30 Issue 3, p395 

    The leading cause of morbidity and mortality in patients with acromegaly is cardiovascular complications. Myocardial exposure to excessive growth hormone can cause ventricular hypertrophy, hypertension, arrhythmia, and diastolic dysfunction. However, congestive heart failure as a result of...

  • Acromegaly with Normal IGF-1 Levels Probably due to Poorly Controlled Diabetes Mellitus. Arihara, Zenei; Sakurai, Kanako; Yamada, Shozo; Murakami, Osamu; Takahashi, Kazuhiro // Tohoku Journal of Experimental Medicine;Dec2008, Vol. 216 Issue 4, p325 

    Acromegaly is characterized by the somatic disfigurement and excessive production of growth hormone (GH) and insulin-like growth factor-1 (IGF-1). Here we report a patient with aromegaly and diabetes mellitus, who showed normal IGF-1 levels in spite of elevated GH levels. The patient was a...

  • Comparing two acromegalic patients with respect to central corneal thickness, intraocular pressure, and tear insulin-like growth factor levels before and after treatment. Emrah, Kan; Elif, Kılıç Kan; Ali, Okuyucu; Elif, Kilic Kan // Indian Journal of Ophthalmology;Sep2015, Vol. 63 Issue 9, p731 

    The aim of the study was to compare the central corneal thickness (CCT), intraocular pressure (IOP), and tear insulin-like growth factor-1 (IGF-1) levels of 2 patients with acromegaly before and after the surgical treatment of the disease. CCTs, IOP levels, and tear IGF-1 values showed a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics